New developments in our understanding of ankylosing spondylitis pathogenesis

Area of Science:

• Immunology
• Genetics
• Rheumatology

Background:

• Ankylosing spondylitis (AS) is an immune-mediated inflammatory arthritis with significant genetic links.
• Type 17 immune responses are increasingly recognized as crucial in AS pathogenesis.
• The gut microbiome's role in AS is a growing area of research.

Purpose of the Study:

• To review recent genetic and animal studies on AS.
• To discuss the role of Type 17 immune cells and cytokines in AS and related spondyloarthritis.
• To explore the influence of the gut microbiome and local joint metabolism on AS.

Main Methods:

• Review of current genetic and animal studies.
• Analysis of clinical data on anti-cytokine monoclonal antibody efficacy.
• Synthesis of emerging research on the gut microbiome and joint metabolism.

Main Results:

• Genetic and animal studies underscore the importance of Type 17 immunity in AS.
• Varied responses to anti-cytokine therapies reveal the complexity of Type 17 pathways in AS.
• Strong evidence implicates the gut microbiome in the development of AS.
• The local metabolic environment within the joint is proposed as a key driver.

Conclusions:

• Type 17 immune responses, gut microbiome, and joint metabolism are critical factors in AS pathogenesis.
• A novel model integrating these elements is proposed for understanding AS development.
• Further research into these interconnected factors is warranted for therapeutic advancements.